Current studentsExisting staffContact us
 

Proteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities

Simple item page
dc.contributor.authorPadhye, B.D.
dc.contributor.authorNawaz, U.
dc.contributor.authorHains, P.G.
dc.contributor.authorReddel, R.R.
dc.contributor.authorRobinson, P.J.
dc.contributor.authorZhong, Q.
dc.contributor.authorPoulos, R.C.
dc.date.issued2024
dc.description.abstractSurvival rates in some paediatric cancers have improved greatly over recent decades, in part due to the identification of diagnostic, prognostic and predictive molecular signatures, and the development of risk-directed therapies. However, other paediatric cancers have proved difficult to treat, and there is an urgent need to identify novel biomarkers that reveal therapeutic opportunities. The proteome is the total set of expressed proteins present in a cell or tissue at a point in time, and is vastly more dynamic than the genome. Proteomics holds significant promise for cancer research, as proteins are ultimately responsible for cellular phenotype and are the target of most anticancer drugs. Here, we review the discoveries, opportunities and challenges of proteomic analyses in paediatric cancer, with a focus on mass spectrometry (MS)- based approaches. Accelerating incorporation of proteomics into paediatric precision medicine has the potential to improve survival and quality of life for children with cancer.
dc.description.statementofresponsibilityBhavna D. Padhye, Urwah Nawaz, Peter G. Hains, Roger R. Reddel, Phillip J. Robinson, Qing Zhong, Rebecca C. Poulos
dc.identifier.citationPediatric Blood and Cancer, 2024; 71(6):e30980-1-e30980-12
dc.identifier.doi10.1002/pbc.30980
dc.identifier.issn0098-1532
dc.identifier.issn0098-1532
dc.identifier.orcidNawaz, U. [0000-0002-3703-4445]
dc.identifier.urihttps://hdl.handle.net/2440/142475
dc.language.isoen
dc.publisherWiley
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/GNT1170739
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/GNT2000855
dc.rights© 2024 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
dc.source.urihttps://doi.org/10.1002/pbc.30980
dc.subjectbiomarkers; machine learning; mass spectrometry; paediatric cancer; precision medicine; proteomics
dc.subject.meshHumans
dc.subject.meshNeoplasms
dc.subject.meshProteome
dc.subject.meshProteomics
dc.subject.meshChild
dc.subject.meshMass Spectrometry
dc.subject.meshBiomarkers, Tumor
dc.subject.meshPrecision Medicine
dc.titleProteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_142475.pdf
Size:
1.03 MB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

Research Outputs